BIOAVAILABILITY AND PHARMACOKINETICS OF CYPROTERONE-ACETATE AFTER ORAL-ADMINISTRATION OF 2.0-MG CYPROTERONE-ACETATE IN COMBINATION WITH 50 MUG ETHINYLESTRADIOL TO 6 YOUNG-WOMEN

被引：22

|

作者：

HUMPEL, M ^{[1
]}

WENDT, H ^{[1
]}

SCHULZE, PE ^{[1
]}

DOGS, G ^{[1
]}

WEISS, C ^{[1
]}

SPECK, U ^{[1
]}

机构：

[1] SCHERING AG,RES LABS,BERLIN,FED REP GER

来源：

CONTRACEPTION | 1977年 / 15卷 / 05期

关键词：

D O I：

10.1016/0010-7824(77)90108-1

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

收藏

页码：579 / 588

页数：10

相关论文

共 23 条

[21] METABOLIC EFFECTS OF 50 MG OF CYPROTERONE-ACETATE COMBINED WITH PERCUTANEOUS 17-BETA-ESTRADIOL DURING THE TREATMENT (6 TO 12 MONTHS) OF 61 PATIENTS
VEXIAU, P
GUEUX, B
FIET, J
VEXIAUROBERT, D
CATHELINEAU, G
ANNALES D ENDOCRINOLOGIE, 1986, 47 (04) : 257 - 257
[22] BIO-AVAILABILITY AND PHARMACOKINETICS OF CYPROTERONE ACETATE-C-14 AND ETHINYLOESTRADIOL-H-3 AFTER ORAL-ADMINISTRATION AS A COATED TABLET (SH B 209 AB)
SPECK, U
WENDT, H
SCHULZE, PE
JENTSCH, D
CONTRACEPTION, 1976, 14 (02) : 151 - 163
[23] COMPARATIVE STUDIES ON ORAL GLUCOSE-TOLERANCE AND SERUM-LIPIDS UNDER INFLUENCE OF A NEW ORAL-CONTRACEPTIVE (SH B 209 AB=2 MG CYPROTERONE-ACETATE + 0,05 MG ETHINYL ESTRADIOL), COMBINATION D-NORGESTREL-ETHINYL ESTRADIOL AND IN A CONTROL-GROUP
SCHILLINGER, E
GERLOFF, C
WELLERSHOFF, S
WENDT, H
LACHNITFIXSON, U
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (12): : 2242 - 2245